Business Wire November 22, 2021
With the Flywheel platform in place, Roche and Genentech researchers can access high-quality images for complex analysis and machine learning, ultimately speeding the development of innovative therapies.
MINNEAPOLIS–(BUSINESS WIRE)–Flywheel, the leading cloud-scale informatics platform for biomedical research and collaboration, announced today the successful integration of its platform by Roche and Genentech, a member of the Roche Group, for ingestion, classification, standardization, curation and analysis of medical imaging data.
@Flywheel_io, @Roche and @genentech team up to speed the development of innovative therapies. See how.
The secure, scalable Flywheel platform enables aggregation and management of medical imaging and associated data to accelerate drug discovery. The data is...
Today's Sponsors
Today's Sponsor